Showing 1 - 16 results of 16 for search 'Veli‐Pekka Harjola', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock by Tuija Sabell, Marek Banaszewski, Johan Lassus, Markku S. Nieminen, Heli Tolppanen, Toni Jäntti, Anu Kataja, Mari Hongisto, Lars Køber, Alessandro Sionis, John Parissis, Tuukka Tarvasmäki, Veli‐Pekka Harjola, Raija Jurkko
Published 2020-04-01
Article -
9
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan by Piergiuseppe Agostoni, Dimitrios T Farmakis, Jose M García-Pinilla, Veli-Pekka Harjola, Kristjan Karason, Dirk von Lewinski, John Parissis, Piero Pollesello, Gerhard Pölzl, Alejandro Recio-Mayoral, Alexander Reinecke, Patrik Yerly, Endre Zima
Published 2019-11-01
Article -
10
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time by Ziad Hijazi, Bertil Lindahl, Jonas Oldgren, Ulrika Andersson, Johan Lindbäck, Christopher B. Granger, John H. Alexander, Bernard J. Gersh, Michael Hanna, Veli‐Pekka Harjola, Elaine M. Hylek, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin
Published 2017-11-01
Article -
11
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. by Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, John Parissis, Kari Pulkki, Tuija Javanainen, Heli Tolppanen, Raija Jurkko, Mari Hongisto, Anu Kataja, Alessandro Sionis, Jose Silva-Cardoso, Marek Banaszewski, Jindrich Spinar, Alexandre Mebazaa, Johan Lassus, CardShock investigators
Published 2019-01-01
Article -
12
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock by Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, Kari Pulkki, Heidi Turkia, Tuija Sabell, Heli Tolppanen, Raija Jurkko, Mari Hongisto, Anu Kataja, Alessandro Sionis, Jose Silva-Cardoso, Marek Banaszewski, Salvatore DiSomma, Alexandre Mebazaa, Mikko Haapio, Johan Lassus, for the CardShock investigators
Published 2021-02-01
Article -
13
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study by Mari Hongisto, Johan Lassus, Tuukka Tarvasmäki, Alessandro Sionis, Jordi Sans‐Rosello, Heli Tolppanen, Anu Kataja, Toni Jäntti, Tuija Sabell, Matias Greve Lindholm, Marek Banaszewski, Jose Silva Cardoso, John Parissis, Salvatore Di Somma, Valentina Carubelli, Raija Jurkko, Josep Masip, Veli‐Pekka Harjola, for the CardShock Study Investigators and the GREAT Network
Published 2021-04-01
Article -
14
2016 ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE by Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, Héctor Bueno, John G. F. Cleland, Andrew J. S . Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A. Jankowska, Mariell Jessup, Cecilia Linde, Petros Nihoyannopoulos, John T . Parissis, Burkert Pieske, Jillian P. Riley, Giuseppe M. C. Rosano, Luis M. Ruilope, Frank Ruschitzka, Frans H. Rutten, Peter van der Meer
Published 2017-02-01
Article -
15
Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Tri... by Antti Saraste, MD, PhD, Haitham Ballo, MD, Olli Arola, MD, PhD, Ruut Laitio, MD, PhD, Juhani Airaksinen, MD, PhD, Marja Hynninen, MD, PhD, Minna Bäcklund, MD, PhD, Emmi Ylikoski, MD, PhD, Johanna Wennervirta, MD, PhD, Mikko Pietilä, MD, PhD, Risto O. Roine, MD, PhD, Veli-Pekka Harjola, MD, PhD, Jussi Niiranen, MD, PhD, Kirsi Korpi, MD, PhD, Marjut Varpula, MD, PhD, Harry Scheinin, MD, PhD, Mervyn Maze, MB ChB, Tero Vahlberg, MSc, Timo Laitio, MD, PhD, for the Xe-HYPOTHECA Study Group, Sami Virtanen, Riitta Parkkola, Jani Saunavaara, Juha Martola, Heli Silvennoinen, Marjaana Tiainen, Juha Grönlund, Outi Inkinen, Päivi Silvasti, Eija Nukarinen, Klaus T. Olkkola
Published 2021-08-01
Article -
16
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use by Zoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, Dominique Bettex, Stefan Bouchez, Dulce Brito, Vladimir Černý, Josep Comin-Colet, Marisa G Crespo-Leiro, Juan F Delgado, Istvan Édes, Alexander A Eremenko, Dimitrios Farmakis, Francesco Fedele, Cândida Fonseca, Sonja Fruhwald, Massimo Girardis, Fabio Guarracino, Veli-Pekka Harjola, Matthias Heringlake, Antoine Herpain, Leo MA Heunks, Tryggve Husebye, Višnja Ivancan, Kristjan Karason, Sundeep Kaul, Matti Kivikko, Janek Kubica, Josep Masip, Simon Matskeplishvili, Alexandre Mebazaa, Markku S Nieminen, Fabrizio Oliva, Julius-Gyula Papp, John Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Alexander Reinecke, Sven-Erik Ricksten, Hynek Riha, Alain Rudiger, Toni Sarapohja, Robert HG Schwinger, Wolfgang Toller, Luigi Tritapepe, Carsten Tschöpe, Gerhard Wikström, Dirk von Lewinski, Bojan Vrtovec, Piero Pollesello
Published 2020-08-01
Article